US Stock Movement: DaVita Healthcare plunges on October 30 due to declining profit margins, rising costs, and Berkshire Hathaway's reduction of holdings

DaVita Healthcare October 30 Significant Drop Analysis

Keywords: Declining profit margins, rising costs, Berkshire Hathaway reducing holdings

1. After the market closed on October 29, the company disclosed its 2026 third quarter results: revenue was $3.578 billion and adjusted earnings per share were $3.82, both exceeding expectations. However, adjusted earnings per share were lower than the second quarter's $4.02, net profit was $223 million, below the second quarter's $265 million, operating profit margin was 14.0%, lower than the second quarter's 16.3%, and free cash flow margin was 7.7%, lower than last year's 19.7% for the same period.

2. The financial report and earnings call on October 29 revealed patient care cost per treatment increased by 2.4% year-on-year, technology spending grew by over 20% year-on-year, costs for labor, medical supplies, and technology all rose, and the fourth quarter is expected to have approximately a 1% headwind in treatment days.

3. On October 27, Berkshire Hathaway sold 382,600 shares at an average price of $180.4305 per share, cashing out around $69.026 million. The SEC disclosed this on October 29 and it was reported on October 30.

4. On October 30, Barclays lowered its target price from $224 to $216.

(Disclaimer: This content is generated by AI technology, summarizing publicly available information for reference only and does not constitute investment advice.)